Tenet Healthcare (THC) Tops Q3 EPS by 24c, Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q3 EPS of $1.44, $0.24 better than the analyst estimate of $1.20. Revenue for the quarter came in at $5.07 billion versus the consensus estimate of $5.02 billion.

GUIDANCE:

Tenet Healthcare sees Q4 2023 EPS of $1.12-$1.74, versus the consensus of $1.75. Tenet Healthcare sees Q4 2023 revenue of $5.131-5.331 billion, versus the consensus of $5.25 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• Home Depot beats estimates, reaffirms fiscal 2026 guidance